Profit / Loss per share
|6 Months Ended|
Jun. 30, 2023
|Profit / Loss per share|
|Profit / Loss per share||
Note 4 — Loss per share
The following tables reconcile the numerator and denominator in the basic and diluted loss per share computation (in thousands):
The dilutive effect of 201,688,491 and 150,711,054 stock options outstanding as of June 30, 2023 and 2022 respectively have been excluded from the diluted loss per share calculation for the three and six months ended June 30, 2023 and 2022 because they would have an antidilutive effect on the loss per share for the period. The stock options outstanding as of June 30, 2023 includes a provisional amount of 35,156,344 replacement awards granted to TCR2 grantholders on June 1, 2023.
The entire disclosure for earnings per share.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef